How Wearable ECG Patches Detect Atrial Fibrillation Earlier

Lucas and Luna explore how wearable ECG patches are enabling earlier detection of atrial fibrillation, the most common heart arrhythmia and a leading cause of stroke. They dive into the clinical study backing the Zio patch by iRhythm, which monitors heart rhythms continuously for up to 14 days — versus a standard 10-second in-office ECG. The hosts discuss the patch's 98% sensitivity rate in detecting AFib, compare it to smartwatch ECG features, and examine why patches may be more effective for paroxysmal AFib. They also touch on the regulatory path, Medicare coverage expansion in 2025, and what this means for the future of preventive cardiology. #WearableECG #AtrialFibrillation #iRhythm #ZioPatch #HeartHealth #ArrhythmiaDetection #StrokePrevention #ContinuousMonitoring #Cardiology #WearableTech #HealthTech #MedicalDevices #PreventiveCare #FDA #Podcast #FexingoBusiness #BusinessPodcast #Technology Keep every episode free: buymeacoffee.com/fexingo